Additional Information:
Increased Serum Adiponectin Concentrations in Amenorrheic Physically

11
Adiponectin is an adipose tissue-specific secretory protein that is expressed exclusively 12 in differentiated adipocytes [11] . In contrast to other adipokines, such as tumor-necrosis factor 13 and interleukin-6, which are upregulated with increasing adiposity, adiponectin concentrations 14 correlate negatively with obesity and insulin resistance [12, 13] . Conversely, adiponectin 15 concentrations have been reported to correlate both positively [14] and negatively [15] with low demonstrated that women have higher adiponectin levels compared to men, independent of body 1 fat mass or body fat distribution [13, 18] , suggesting that circulating gonadal steroids may affect 2 adiponectin secretion [19] . To date, however, there have been no reports describing whether 3 estrogen exposure, as assessed by daily urinary analysis of ovarian steroids over time, is mediated 4 by nutritionally regulated hormones, such as adiponectin, in young adult physically active 5 amenorrheic women. Such assessment may increase the ability to detect estrogenic associations, 6 when present, compared with one-time sample serum measures of estradiol.
7
The objectives of the current study were threefold. In eumenorrheic ovulatory athletes 8 and amenorrheic athletes, to explore: 1) the relationship between adiponectin concentrations and 9 gonadal status (i.e., estrogen exposure) as assessed via daily urinary measures over time; 2) the 10 relationship between adiponectin and nutritionally mediated factors known to be altered in 11 response to energy deficiency, including TT3 and resting energy expenditure; and 3) the 12 associations between adiponectin, body composition, body fat distribution and bone health. We 13 hypothesized that compared to estrogen replete women, hypoestrogenic physically active adult 14 premenopausal women with energy deficiency associated amenorrhea (EDAA) would 15 demonstrate elevated serum adiponectin concentrations, and that these concentrations would yrs; 2) good health determined by a medical exam; 3) no chronic illness, including 1 hyperprolactinemia, polycystic ovarian syndrome, and thyroid disease; 4) stable self reported 2 menstrual status (i.e., same menstrual status) over the preceding 3 months, with menstruating 3 women having cycle lengths between 25-35 days, and athletic women with secondary 4 amenorrhea having not menstruated for at least 90 consecutive days [4]; 5) non-smoking; 6) not 5 currently dieting and weight stable for the preceding 3 months, as determined by self-report; 7) 6 absence of hormonal therapy for at least 12 months; 8) no history or current clinical diagnosis of 7 eating disorders and 9) no other contraindications that would preclude participation in the study.
8
The study was approved by the institutional committee on human research by the Ethics Review
9
Board at the University of Toronto, and confirmed to the standards set by the latest revision of the 10 Declaration of Helsinki. All volunteers signed an approved informed consent document.
12
Experimental Design
13
We originally conducted a prospective observational study on a rolling basis over 2-3 14 years to examine relationships between physical activity, metabolism, cardiovascular health and 15 reproductive function. Fifty-two women completed the entire study, with 34 of these 52 being 16 included in the current post-hoc study. The relationship between estrogen exposure and 17 numerous metabolic and nutritionally regulated hormones on cardiovascular function in a subset 18 of these women have previously been described by our laboratory [6, 20] . However, the potential 19 for nutritionally regulated hormones, specifically adiponectin, and indices of metabolic status, 20 namely TT3 and REE, to predict gonadal status has not been previously reported by our group.
22
Observational Time Periods
23
Menstruating women were monitored for 2 to 3 consecutive menstrual cycles, and 24 amenorrheic women were monitored for 2 to 3 consecutive 30-day monitoring periods. All 25 measures, except urinary measures which were assessed daily, were obtained during the early follicular phase (days 2-6) across two-to three menstrual cycles for menstruating women, and 1 during days 1-6 of each 30-day monitoring period for amenorrheic women. The mean of these 2 measures were used in statistical analyses.
4
Exercise and Menstrual Status
5
Exercise status was defined as "sedentary" when purposeful exercise was less than 2 6 hours per week and "exercising" when purposeful exercise was more than 2 hours per week [21] .
7
Purposeful exercise, defined as exercise that elicited a heart rate (HR) greater than 55% of 8 maximal HR (220 minus age) for 3 minutes or more, was documented in exercise logs [6] . HR 9 was determined by the subject counting heart beats during a 10 second period of carotid artery 10 palpation after each exercise bout. In conjunction with the hours of exercise activity criterion, we 11 also utilized a VO 2 max of <40 ml/kg/min to reflect sedentary status and 40 ml/kg/min or greater 12 to reflect exercising status consistent with published data of this parameter [22] .
13
Menstrual status was determined from daily first morning void urine samples collected by 14 all participants for the duration of the study period. 
18
As previously reported by our group [6, 7] urinary E1G and log PdG exposure (see Table   19 2), determined by the AUC trapezoidal method, was significantly lower (p=0. measures (see Table 3 ). As expected, log leptin was positively associated (p<0.05) with all 10 indices of adiposity. In contrast, log adiponectin adjusted for fat mass (kg) was negatively 11 associated (p<0.05) with all indices of adiposity. 
Similarly, others have also reported an inverse association between serum adiponectin and 19 visceral fat [38] . These findings [16, 38] , and that of the current study, supports the postulate that 20 distribution of body fat rather than total fat amount may be important to adiponectin metabolism.
21
This hypothesis awaits further investigation.
23
Limitations
24
While the primary objectives of this study were to examine serum adiponectin levels in 25 physically active women with EDAA and to examine whether this nutritionally regulated hormone could predict gonadal status or bone health, the current study only examines 1 associations, not cause and effect. In addition, our chosen method to determine predictors of 2 adiponectin, gonadal status and bone health may not be optimal. As such, these associations and 3 predictions should be interpreted appropriately. We also failed to examine differences between 4 varying molecular weight adiponectin molecules, and we did not examine all possible urinary 5 estrone conjugates. It is possible that differences exist between low, medium, high, and total 6 molecular weight adiponectin, and between the different estrone conjugates in adult amenorrheic 7 athletes. Finally, our study groups were of small sample size, and may have therefore affected 8 our ability to detect true associations where present. As such, our findings should be interpreted 9 prudently.
11
CONCLUSION
12
We demonstrate for the first time that total serum adiponectin levels relative to fat mass 
Serum Measures
Adiponectin (mg/L) 8.2 ± 0. Adipon, adiponectin; EIG, urinary estrone 3-glucuronide; AUC, area under the curve; TT3, total triiodothyronine; FM, fat mass; Periph, peripheral; REE, resting energy expenditure; FFM, fat free mass; BMD, bone mineral density. * Using pooled data (all women, n=34). Significant correlations are bolded. All women, n=34. * signifies log adjusted data 
